Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
40,247,966
-
Share change
-
-1,298,135
-
Total reported value
-
$5,110,298,381
-
Put/Call ratio
-
100%
-
Price per share
-
$126.96
-
Number of holders
-
834
-
Value change
-
-$166,074,410
-
Number of buys
-
239
-
Number of sells
-
376
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q2 2023
As of 30 Jun 2023,
ISHARES TR - ISHARES BIOTECH (IBB) was held by
834 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,247,966 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, MORGAN STANLEY, CITIGROUP INC, JPMORGAN CHASE & CO, UBS Group AG, BNP PARIBAS ARBITRAGE, SNC, Royal Bank of Canada, GOLDMAN SACHS GROUP INC, COMMERCE BANK, and HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND.
This page lists
835
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.